NCT01007929View on ClinicalTrials.gov

Open-Label Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetics (PK) Following a Single Oral Dose of AZD1236 in Healthy Male Subjects

PHASE1TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

October 31, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy
Interventions
DRUG

14C-AZD1236

Oral solution 1mg/mL

Trial Locations (1)

Unknown

Research Site, Macclesfield

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY